1. A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine‐Rich Repeat Kinase 2 Mutation. Issue 2 (12th June 2021) Authors: Ahamadi, Malidi; Mehrotra, Nitin; Hanan, Nathan; Lai Yee, Ka; Gheyas, Ferdous; Anton, Judith; Bani, Massimo; Boroojerdi, Babak; Smit, Hans; Weidemann, Jonas; Macha, Sreeraj; Thuillier, Vincent; Chen, Chao; Yang, Minhua; Williams‐Gray, Caroline H.; Stebbins, Glenn T.; Pagano, Gennaro; Hang, Yaming... Journal: Clinical pharmacology & therapeutics Issue: Volume 110:Issue 2(2021) Page Start: 508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs. Issue 3 (5th December 2019) Authors: Ahamadi, Malidi; Conrado, Daniela J; Macha, Sreeraj; Sinha, Vikram; Stone, Julie; Burton, Jackson; Nicholas, Timothy; Gallagher, Jill; Dexter, David; Bani, Massimo; Boroojerdi, Babak; Smit, Hans; Weidemann, Jonas; Chen, Chao; Yang, Minhua; Maciuca, Romeo; Lawson, Rachael; Burn, David; Marek, Kenn... Journal: Clinical pharmacology & therapeutics Issue: Volume 107:Issue 3(2020) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗